We are thrilled to share that the European project EUCanScreen: Joint European Action for the Implementation of Cancer Screening Programs in the EU was presented at the 5th Panhellenic Congress “Present and Future in Oncology” on June 12th, 2025.
📍 The event, held at the Achaia Beach Hotel in Patras, was organized by the Hellenic Society of Geriatric Oncology in collaboration with prestigious organizations, including the Oncology Department of the Pathology Clinic of the University General Hospital of Patras, ESYN/HeCOG, and under the auspices of the Society of Oncologists of Greece and the Patras Medical Association.
👩⚕️ Dr. Anna Vicha, a valued member of the scientific team from the 6th DYPEDE and Head of Diary Hospitalization at the University General Hospital of Patras, represented the project during the event.
🇬🇷 Greece actively participates in EUCanScreen through the Ministry of Health and the interconnected 6th DYPEDE entity. Professor Apostolos Vantarakis, from the Department of Medicine of the University of Patras, leads Work Package 2 (Dissemination) and contributes significantly to all work packages.
🌟 EUCanScreen aims to ensure the sustainability of high-quality cancer screening programs across Europe, including breast, cervical, colorectal, lung, prostate, and stomach cancers. Its mission is to reduce cancer rates and achieve healthcare equality for all EU citizens.
💪 Together, we strive for a healthier future!
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959